{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:31:14Z","timestamp":1785547874225,"version":"3.56.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2023\/000616"],"award-info":[{"award-number":["CRG\/2023\/000616"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cellsig.2026.112399","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:29:47Z","timestamp":1769844587000},"page":"112399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Potential role of splice junctions of \u03b1-synuclein isoforms in the activation of T-cells: Implications for Parkinson's disease"],"prefix":"10.1016","volume":"141","author":[{"given":"Shweta","family":"Kaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Vulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasi V.","family":"Kalivendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112399_bb0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","article-title":"Parkinson\u2019s disease","volume":"65","author":"Mhyre","year":"2012","journal-title":"Subcell. Biochem."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112399_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","article-title":"The Lewy body in Parkinson\u2019s disease: molecules implicated in the formation and degradation of \u03b1-synuclein aggregates","volume":"27","author":"Wakabayashi","year":"2007","journal-title":"Neuropathology"},{"issue":"6645","key":"10.1016\/j.cellsig.2026.112399_bb0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112399_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112399_bb0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","article-title":"Alpha-synuclein in Lewy body disease and Alzheimer\u2019s disease","volume":"9","author":"Hashimoto","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.cellsig.2026.112399_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.cellsig.2026.112399_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/308654","article-title":"Evidence of inflammatory system involvement in Parkinson\u2019s disease","volume":"2014","author":"Chao","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"7660","key":"10.1016\/j.cellsig.2026.112399_bb0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature22815","article-title":"T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides","volume":"546","author":"Sulzer","year":"2017","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112399_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/life10070101","article-title":"Interaction of oxidative stress and misfolded proteins in the mechanism of neurodegeneration","volume":"10","author":"Abramov","year":"2020","journal-title":"Life"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112399_bb0050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.1003013","article-title":"Neuroinflammation and \u03b1-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"119","author":"Gao","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112399_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson\u2019s disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112399_bb0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112399_bb0065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112399_bb0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated \u03b1-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"issue":"7638","key":"10.1016\/j.cellsig.2026.112399_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112399_bb0080","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson\u2019s disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Movement Disorders"},{"issue":"22","key":"10.1016\/j.cellsig.2026.112399_bb0085","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.3390\/ijms21228765","article-title":"Ferroptosis mechanisms involved in neurodegenerative diseases","volume":"21","author":"Reichert","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112399_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.548283","article-title":"The role of glial mitochondria in \u03b1-synuclein toxicity","volume":"8","author":"Jeon","year":"2020","journal-title":"Front. Cell Develop. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112399_bb0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12974-024-03221-5","article-title":"Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy","volume":"21","author":"Joers","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112399_bb0100","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that \u03b1-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112399_bb0105","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1073\/pnas.1324209111","article-title":"Splice isoform and pharmacological studies reveal that sterol depletion relocalizes \u03b1-synuclein and enhances its toxicity","volume":"111","author":"Valastyan","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2026.112399_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2022.111759","article-title":"Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic","volume":"209","author":"Hassanzadeh","year":"2023","journal-title":"Mech. Ageing Dev."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112399_bb0115","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bpj.2010.06.035","article-title":"The N-terminus of the intrinsically disordered protein \u03b1-synuclein triggers membrane binding and helix folding","volume":"99","author":"Bartels","year":"2010","journal-title":"Biophys. J."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112399_bb0120","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1021\/acschemneuro.8b00140","article-title":"Identification of an alternatively spliced \u03b1-synuclein isoform that generates a 41-amino acid N-terminal truncated peptide, 41-syn: role in dopamine homeostasis","volume":"9","author":"Vinnakota","year":"2018","journal-title":"ACS Chem. Nerosci."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112399_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313465121","article-title":"Modulation of \u03b1-synuclein in vitro aggregation kinetics by its alternative splice isoforms","volume":"121","author":"R\u00f6ntgen","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2026.112399_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10048-007-0106-0","article-title":"Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases","volume":"9","author":"Beyer","year":"2008","journal-title":"Neurogenetics"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112399_bb0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JPD-150642","article-title":"The synaptic function of \u03b1-synuclein","volume":"5","author":"Burr\u00e9","year":"2015","journal-title":"J. Parkinsons Dis."},{"issue":"34","key":"10.1016\/j.cellsig.2026.112399_bb0140","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of \u03b1-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112399_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098657","article-title":"The chaperone-like activity of \u03b1-synuclein attenuates aggregation of its alternatively spliced isoform, 112-synuclein in vitro: plausible cross-talk between isoforms in protein aggregation","volume":"9","author":"Manda","year":"2014","journal-title":"PloS One"},{"issue":"34","key":"10.1016\/j.cellsig.2026.112399_bb0150","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of \u03b1-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112399_bb0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40478-022-01374-z","article-title":"Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of \u03b1-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function","volume":"10","author":"Creed","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"82","key":"10.1016\/j.cellsig.2026.112399_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","article-title":"Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration","author":"Paumier","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112399_bb0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/mps5020020","article-title":"Optimization of peripheral blood mononuclear cell extraction from small volume of blood samples: potential implications for children-related diseases","volume":"5","author":"Patrone","year":"2022","journal-title":"Methods Protocols."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112399_bb0170","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3389\/fneur.2018.00946","article-title":"The peripheral inflammatory response to alpha-synuclein and endotoxin in Parkinson\u2019s disease","author":"White","year":"2018","journal-title":"Front. Neurol."},{"issue":"38","key":"10.1016\/j.cellsig.2026.112399_bb0175","doi-asserted-by":"crossref","first-page":"15731","DOI":"10.1074\/jbc.M117.791863","article-title":"The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice","volume":"292","author":"Amireddy","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112399_bb0180","article-title":"Capturing T lymphocytes\u2019 dynamic interactions with human neural cells using time-lapse microscopy","author":"Lema\u00eetre","year":"2021","journal-title":"Front. Immunol."},{"issue":"6109","key":"10.1016\/j.cellsig.2026.112399_bb0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112399_bb0190","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awt037","article-title":"Prion-like spreading of pathological \u03b1-synuclein in brain","volume":"136","author":"Masuda-Suzukake","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cellsig.2026.112399_bb0195","first-page":"1","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.cellsig.2026.112399_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-018-0587-0","article-title":"Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment","volume":"6","author":"Okuzumi","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112399_bb0205","doi-asserted-by":"crossref","first-page":"716","DOI":"10.15252\/emmm.201607305","article-title":"Seeding and transgenic overexpression of alpha-synuclein triggers dendritic spine pathology in the neocortex","volume":"9","author":"Blumenstock","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"39","key":"10.1016\/j.cellsig.2026.112399_bb0210","doi-asserted-by":"crossref","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","article-title":"Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2026.112399_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-9-43","article-title":"Alpha-synuclein and tau: teammates in neurodegeneration?","volume":"9","author":"Moussaud","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112399_bb0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07391102.2003.10506918","article-title":"A protein-chameleon: conformational plasticity of \u03b1-synuclein, a disordered protein involved in neurodegenerative disorders","volume":"21","author":"Uversky","year":"2003","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112399_bb0225","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein","volume":"34","author":"Giasson","year":"2002","journal-title":"Neuron"},{"issue":"47","key":"10.1016\/j.cellsig.2026.112399_bb0230","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous \u03b1-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6301","key":"10.1016\/j.cellsig.2026.112399_bb0235","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112399_bb0240","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/cells11111732","article-title":"Alpha-synuclein aggregation pathway in Parkinson\u2019s disease: current status and novel therapeutic approaches","volume":"11","author":"Vidovi\u0107","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112399_bb0245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2990.2004.00572.x","article-title":"Differential expression of \u03b1-synuclein isoforms in dementia with Lewy bodies","volume":"30","author":"Beyer","year":"2004","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112399_bb0250","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1389203717666160314151706","article-title":"Alteration of structure and aggregation of \u03b1-synuclein by familial Parkinson\u2019s disease associated mutations","volume":"18","author":"Sahay","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112399_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz9165","article-title":"Identification of distinct pathological signatures induced by patient-derived \u03b1-synuclein structures in nonhuman primates","volume":"6","author":"Bourdenx","year":"2020","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112399_bb0260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5483\/BMBRep.2022.55.7.073","article-title":"Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson\u2019s disease","volume":"55","author":"Yoo","year":"2022","journal-title":"BMB Rep."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112399_bb0265","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1039\/D1CS00991E","article-title":"Dissecting the role of protein phosphorylation: a chemical biology toolbox","volume":"51","author":"Bilbrough","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112399_bb0270","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.3390\/ijms20215312","article-title":"The overcrowded crossroads: mitochondria, alpha-synuclein, and the endo-lysosomal system interaction in Parkinson\u2019s disease","volume":"20","author":"Lin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112399_bb0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41598-022-26899-0","article-title":"Ubiquilin-2 regulates pathological alpha-synuclein","volume":"13","author":"Sandoval-Pistorius","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112399_bb0280","doi-asserted-by":"crossref","first-page":"207","DOI":"10.37349\/ent.2023.00048","article-title":"Targeting \u03b1-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson\u2019s disease","volume":"3","author":"Henriquez","year":"2023","journal-title":"Explorat. Neuroprotect. Therapy"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112399_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-140491","article-title":"Role of \u03b1-synuclein in inducing innate and adaptive immunity in Parkinson disease","volume":"5","author":"Allen Reish","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.cellsig.2026.112399_bb0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","article-title":"Peripheral monocyte entry is required for alpha-synuclein induced inflammation and neurodegeneration in a model of Parkinson disease","volume":"300","author":"Harms","year":"2018","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112399_bb0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.freeradbiomed.2009.10.045","article-title":"Oxidants induce alternative splicing of \u03b1-synuclein: implications for Parkinson\u2019s disease","volume":"48","author":"Kalivendi","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cellsig.2026.112399_bb0300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fcell.2020.00405","article-title":"\u03b1-Synuclein-112 impairs synaptic vesicle recycling consistent with its enhanced membrane binding properties","volume":"8","author":"Soll","year":"2020","journal-title":"Front. Cell Develop. Biol."},{"issue":"147","key":"10.1016\/j.cellsig.2026.112399_bb0305","article-title":"The autoimmune response induced by \u03b1-synuclein peptides drives neuronal cell death and glial cell activation","author":"Choe","year":"2024","journal-title":"J. Autoimmun."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112399_bb0310","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1093\/brain\/awaa269","article-title":"CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease","volume":"143","author":"Galiano-Landeira","year":"2020","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112399_bb0315","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/s41593-024-01775-4","article-title":"Modeling Parkinson\u2019s disease pathology in human dopaminergic neurons by sequential exposure to \u03b1-synuclein fibrils and proinflammatory cytokines","volume":"27","author":"Bayati","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112399_bb0320","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1016\/j.neuron.2023.07.015","article-title":"Interaction of an \u03b1-synuclein epitope with HLA-DRB1\u2217 15: 01 triggers enteric features in mice reminiscent of prodromal Parkinson\u2019s disease","volume":"111","author":"Garretti","year":"2023","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112399_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42051","article-title":"A single-cell transcriptome analysis reveals astrocyte heterogeneity and identifies CHI3L1 as a diagnostic biomarker in Parkinson\u2019s disease","volume":"11","author":"Gong","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.cellsig.2026.112399_bb0330","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fneur.2020.00658","article-title":"Elevated percentage of CD3+ T-cells and CD4+\/CD8+ ratios in multiple system atrophy patients","volume":"11","author":"Cao","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cellsig.2026.112399_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726421","article-title":"Microglia and perivascular macrophages act as antigen presenting cells to promote CD8 T cell infiltration of the brain","volume":"12","author":"Goddery","year":"2021","journal-title":"Front. Immunol."},{"issue":"7745","key":"10.1016\/j.cellsig.2026.112399_bb0340","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-0964-2","article-title":"\u03b2-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration","volume":"566","author":"Lodygin","year":"2019","journal-title":"Nature"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:42:29Z","timestamp":1776825749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":68,"alternative-id":["S0898656826000495"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112399","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential role of splice junctions of \u03b1-synuclein isoforms in the activation of T-cells: Implications for Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112399"}}